Clinical Trial Update: Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

The document reports the completed Phase I trial of TdCyd (4'-Thio-2'-Deoxycytidine) in patients with advanced solid tumors, sponsored by the National Cancer In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Solid Tumors

Drugs mentioned

• TdCyd (4'-Thio-2'-Deoxycytidine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms, Solid Tumors | Phase 1 | Status: COMPLETED